D7295

Harvest of bone for use in autogenous grafting procedure

Code Summary

D7295 is the CDT code for the harvest of bone for use in an autogenous grafting procedure — surgically collecting (harvesting) the patient's own bone from one site, to be used as a graft elsewhere in the patient. 'Autogenous' means the bone comes from the same person (the patient's own bone). This code is for the harvesting procedure itself (a separate surgical step at the donor site), reported in addition to the grafting procedure where the harvested bone is placed.

What D7295 means

D7295 covers the harvest of bone for use in an autogenous grafting procedure. "D" is dental, "72" is this oral surgery group, and "95" is this bone harvest. In bone grafting, bone is placed at a site that needs more bone (e.g., to build up a ridge for an implant, or to fill a defect). The graft material can come from various sources — including the patient's own bone (autogenous/autograft), which is often considered an excellent graft material (it contains the patient's own living bone cells and is fully compatible). When the patient's own bone is used, it must be harvested (surgically collected) from a donor site in the patient (e.g., another area of the jaw, or sometimes elsewhere) to then be placed at the recipient (graft) site. D7295 is for this harvesting procedure — the surgical step of collecting the bone from the donor site. 'Autogenous' (or autograft) means the graft is from the same individual (the patient's own tissue).

So it's the procedure of surgically collecting the patient's own bone from a donor site, to be used as a graft material elsewhere in the same patient.

D7295 represents the harvesting as a distinct procedure (the work of accessing the donor site and collecting the bone), separate from the grafting procedure where the harvested bone is actually placed (which is reported with its own code — e.g., a bone graft/ridge augmentation/sinus graft code, depending on where the bone is placed). So when autogenous bone is harvested for a graft, D7295 reports the harvest, and the placement is reported separately. The note that the bone is harvested from the patient who will then receive it (in another location) is key — it's the patient's own bone, moved from one site to another. Autogenous bone is used because of its advantages (its own bone cells, good integration). The harvest adds a donor-site procedure (with its own healing). Coverage and documentation reflect the harvest as a component of the overall grafting treatment.

When it's typically used

D7295 is reported for harvesting the patient's own bone (autogenous bone) from a donor site, to be used as a graft elsewhere in the same patient. It's reported in addition to the grafting procedure (where the harvested bone is placed). It's used when autogenous (the patient's own) bone is chosen as the graft material, requiring this separate harvesting step.

How much does D7295 cost?

The harvest of bone for autogenous grafting is a moderate-to-significant additional fee, often roughly 400 to 1,200+ USD depending on region, the donor site, and the amount harvested — for the harvesting procedure itself (separate from the grafting procedure where the bone is placed, which has its own fee). Using autogenous bone (with a harvest) adds this donor-site cost to the overall grafting. Verify your specific coverage.

Is D7295 covered by insurance?

Reported in addition to the grafting procedure (where the harvested bone is placed). Documentation of the harvest (the donor site, the autogenous bone collected) as a component of the overall autogenous grafting supports the claim. Coverage depends on the plan and the overall grafting procedure's coverage (grafting for some purposes — e.g., for implants — may have specific coverage considerations). It's a distinct procedure from the graft placement. Verifying coverage for the overall grafting treatment helps.

What autogenous bone harvesting is

Harvesting the patient's own bone clarifies what this code covers.

Understanding autogenous bone harvesting clarifies D7295. In bone grafting, a graft (bone material) is placed where more bone is needed. 'Autogenous' (autograft) means using the patient's own bone as the graft — bone taken from one site in the patient and placed at another site in the same patient. To use the patient's own bone, it must first be harvested (surgically collected) from a donor site — this collecting procedure is what D7295 covers. The donor site is somewhere the bone can be taken from — often another area within the mouth/jaw (intraoral donor sites, e.g., the chin/symphysis, the ramus/back of the lower jaw, or other areas), and in some cases an extraoral site (elsewhere in the body, for larger amounts). The harvested bone is then used at the recipient (graft) site. So D7295 is the harvesting step — accessing the donor site and collecting the bone.

This is a distinct surgical procedure: it involves its own access (an incision/flap at the donor site), collecting the bone (e.g., as a block of bone, or particulate bone shavings/chips), and closing the donor site (which then heals). It's a separate component of the overall grafting (which also includes placing the harvested bone at the recipient site — a separate procedure/code). So D7295 specifically is the harvest (the donor-site work). The surgeon performs the harvest as part of an autogenous grafting treatment. For patients, understanding what autogenous bone harvesting is — collecting the patient's own bone from a donor site — clarifies the code. It collects the patient's own bone. The surgeon harvests it. Understanding this helps patients see that autogenous bone harvesting (D7295) is the procedure of surgically collecting the patient's own bone from a donor site (often another area of the jaw/mouth, sometimes elsewhere in the body) to be used as a graft at another site in the same patient — a distinct surgical step (accessing the donor site, collecting the bone as a block or particulate, and closing the site) that's a separate component of the overall autogenous grafting (which also includes placing the harvested bone at the recipient site), so D7295 specifically covers the harvest.

Why use the patient's own bone

Autogenous bone has advantages, and understanding them clarifies why it's used.

Using the patient's own bone (autogenous bone) has advantages that make it valuable for grafting — and understanding them clarifies why it's used (and harvested). Graft material can come from different sources: autogenous (the patient's own bone), allograft (donated human bone, processed), xenograft (animal-derived, e.g., bovine), or alloplast (synthetic). Autogenous bone is often considered an excellent (sometimes the 'gold standard') graft material because: it's the patient's own living tissue — it can contain the patient's own living bone cells (and growth factors), which can actively contribute to forming new bone (osteogenic potential), and it provides a natural scaffold; it's fully compatible — being the patient's own tissue, there's no risk of immune rejection or disease transmission (which are considerations, though minimized, for other sources); and it integrates well — it tends to integrate and form bone effectively. So autogenous bone offers strong biological performance.

The trade-off is the harvest — using autogenous bone requires the additional harvesting procedure (D7295) at a donor site, which means a second surgical site (with its own healing, and some additional morbidity — discomfort, healing at the donor site). So the surgeon weighs the benefits of autogenous bone against the added harvest (vs using a graft from another source that doesn't require harvesting). Autogenous bone is often chosen when its advantages are valued (e.g., for certain larger or more demanding grafts, or when the best biological performance is desired). So the patient's own bone is used for its advantages, with the harvest as the trade-off. The surgeon decides based on the case. For patients, understanding why the patient's own bone is used — its biological advantages — clarifies the rationale. It's an excellent graft material. The surgeon chooses it when valued. Understanding this helps patients see that the patient's own bone (autogenous bone) is often used because it has advantages — it's the patient's own living tissue (potentially containing living bone cells and growth factors that actively help form new bone), it's fully compatible (no rejection or disease-transmission risk), and it integrates well — making it an excellent (often 'gold standard') graft material, with the trade-off being the additional harvesting procedure (D7295) at a donor site (a second surgical site with its own healing), so the surgeon chooses autogenous bone (and the harvest) when its biological advantages are valued for the case.

The harvest as a separate procedure

The harvest is reported separately from the graft, and understanding this clarifies the coding.

The bone harvest (D7295) is a separate procedure from the grafting where the bone is placed — and understanding this clarifies the coding. The overall autogenous grafting treatment has two main surgical components: the harvest — collecting the bone from the donor site (D7295 — this code); and the graft placement — placing the harvested bone at the recipient site (reported with the appropriate grafting code for that site/purpose — e.g., a ridge augmentation, a sinus augmentation/graft, a bone graft for a defect, or another grafting code, depending on where and why the bone is placed). So D7295 (the harvest) is reported in addition to the grafting code (the placement). This reflects that the harvest is distinct work (a separate surgical site and effort) beyond placing the graft.

This separate reporting makes sense because: the harvest is its own procedure (its own access, collection, and donor-site closure/healing), adding work and a second site; and the graft placement is a different procedure (at a different site, with its own work). When a graft uses a source that doesn't require harvesting (e.g., an allograft or synthetic material — which come ready to use), there's no harvest procedure (just the placement). But for autogenous bone, the harvest (D7295) is the additional component. So the coding captures both the harvest (D7295) and the placement (the grafting code) for autogenous grafting. The surgeon reports both components. For patients, understanding that the harvest is reported separately from the graft clarifies the coding. The harvest and placement are separate. The surgeon reports both. Understanding this helps patients see that the bone harvest (D7295) is a separate procedure from the grafting where the bone is placed — the overall autogenous grafting having two components, the harvest (D7295, collecting the bone from the donor site) and the graft placement (reported with the appropriate grafting code for the recipient site/purpose) — so D7295 is reported in addition to the grafting code, reflecting the harvest as distinct work (a separate site and effort), whereas grafts using ready-to-use sources (allograft, synthetic) don't have a harvest procedure (just the placement).

The donor site and healing

The donor site involves its own healing, and understanding this clarifies the experience.

The bone harvest involves a donor site that has its own healing — and understanding this clarifies the patient experience. When autogenous bone is harvested (D7295), the donor site (where the bone is taken from) is a surgical site that must heal: the procedure — at the donor site, the surgeon makes an incision/flap, collects the bone (a block or particulate), and closes the site; the healing — the donor site then heals (the soft tissue closing, and the bone area healing/regenerating over time); and the experience — the patient has this additional surgical site (beyond the recipient/graft site), which means additional post-operative care, some discomfort/swelling at the donor site, and its healing time. So the harvest adds a donor-site component to the recovery.

The specifics depend on the donor site (e.g., an intraoral site like the ramus or chin has its own considerations; an extraoral site is a different situation). The surgeon chooses the donor site based on the amount of bone needed and the case, aiming to harvest adequate bone while minimizing donor-site morbidity. The added donor site is part of the trade-off of using autogenous bone (its advantages vs the additional site). The surgeon manages the donor site (the harvest, closure, and healing) as part of the care. So the donor site involves its own healing, part of the autogenous grafting experience. The surgeon manages it. For patients, understanding that the donor site involves its own healing clarifies the experience. The donor site heals separately. The surgeon manages it. Understanding this helps patients see that the bone harvest (D7295) involves a donor site (where the bone is taken) that has its own healing — the surgeon making an incision/flap, collecting the bone, and closing the site, which then heals (with the patient having this additional surgical site, additional post-operative care, some donor-site discomfort/swelling, and its healing time) — with the specifics depending on the donor site chosen (an intraoral site like the ramus/chin, or sometimes an extraoral site), and the surgeon selecting the site to harvest adequate bone while minimizing donor-site morbidity, managing the donor site as part of the overall autogenous grafting care.

Frequently asked questions

What is the D7295 dental code?
It's the harvest of bone for use in an autogenous grafting procedure — surgically collecting the patient's own bone from a donor site, to be used as a graft elsewhere in the same patient. It's the harvesting step (a separate procedure), reported in addition to the grafting procedure where the harvested bone is placed.
What does 'autogenous' mean?
It means the graft comes from the same individual — the patient's own bone (an autograft). The bone is taken from one site in the patient and placed at another site in the same patient. This is different from allograft (donated human bone), xenograft (animal-derived), or alloplast (synthetic).
Why use the patient's own bone?
Autogenous bone is often considered an excellent (sometimes 'gold standard') graft material — it's the patient's own living tissue (potentially with living bone cells and growth factors that help form new bone), fully compatible (no rejection or disease-transmission risk), and integrates well. The trade-off is the additional harvesting procedure (a second surgical site).
Where is the bone harvested from?
From a donor site in the patient — often another area of the jaw/mouth (intraoral sites like the chin/symphysis or the ramus/back of the lower jaw), and in some cases an extraoral site (elsewhere in the body, for larger amounts). The surgeon chooses the site based on the amount of bone needed and the case.
Is this the whole grafting procedure?
No — D7295 is just the harvest (collecting the bone). The placement of the harvested bone at the recipient site is a separate procedure, reported with its own grafting code (e.g., a ridge augmentation, sinus graft, or bone graft code, depending on where/why). So both the harvest (D7295) and the placement are reported.
How much does it cost?
Often around 400 to 1,200+ USD for the harvest itself (depending on the donor site and amount), separate from the grafting procedure where the bone is placed (which has its own fee). Using autogenous bone (with a harvest) adds this donor-site cost to the overall grafting. Verify your specific coverage.

This page is an independent, plain-language explanation for general information only. It is not billing, coding, or clinical advice. For the official CDT descriptor and current-year wording, refer to the American Dental Association.